| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Applied Molecular Transport Inc. | Chief Bus. & Strategy Officer | Common Stock | 48.8K | $7.97K | $0.16 | Feb 15, 2022 | Direct |
| Applied Molecular Transport Inc. | Chief Bus. & Strategy Officer | Stock Option (Right to Buy) | 80.5K | Feb 15, 2022 | Direct | ||
| eFFECTOR Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 800 | Jun 13, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| EFTR | eFFECTOR Therapeutics, Inc. | Jun 13, 2024 | 1 | $0 | 4 | Jun 13, 2024 | Director |
| EFTR | eFFECTOR Therapeutics, Inc. | Feb 19, 2024 | 1 | $0 | 4 | Feb 21, 2024 | Director |
| EFTR | eFFECTOR Therapeutics, Inc. | Jun 22, 2023 | 1 | $0 | 4 | Jun 22, 2023 | Director |
| EFTR | eFFECTOR Therapeutics, Inc. | Jan 20, 2023 | 1 | $0 | 4 | Jan 24, 2023 | Director |
| EFTR | eFFECTOR Therapeutics, Inc. | Jun 9, 2022 | 1 | $0 | 4 | Jun 13, 2022 | Director |
| AMTI | Applied Molecular Transport Inc. | Feb 15, 2022 | 2 | $0 | 4 | Feb 16, 2022 | Chief Bus. & Strategy Officer |
| AMTI | Applied Molecular Transport Inc. | Dec 24, 2021 | 1 | $0 | 4 | Jan 6, 2022 | Chief Bus. & Strategy Officer |
| EFTR | eFFECTOR Therapeutics, Inc. | Oct 6, 2021 | 1 | $0 | 4 | Oct 8, 2021 | Director |
| EFTR | eFFECTOR Therapeutics, Inc. | Aug 25, 2021 | 3 | $0 | 4 | Aug 27, 2021 | Director |
| AMTI | Applied Molecular Transport Inc. | Jul 21, 2021 | 4 | -$289K | 4 | Jul 22, 2021 | Chief Bus. & Strategy Officer |